67 filings
Page 2 of 4
FWP
82m6ukrgq0f07uvwbnv
10 Jul 17
Free writing prospectus
12:00am
8-K
bj07jn3go xnsuc
26 May 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
nos4ttwp
12 May 17
PhaseRx Reports First Quarter 2017 Financial Results and Provides Corporate Update
12:00am
DEF 14A
eiw2gb rnpcj
13 Apr 17
Definitive proxy
12:00am
8-K
1cnz876x px
27 Mar 17
PhaseRx Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update
12:00am
S-8
ixz lxktnpbm
27 Mar 17
Registration of securities for employees
12:00am
10-K
8d6sdwfbqrhgebqnw
27 Mar 17
Annual report
12:00am
8-K
hpbwbc2tckl hw
8 Mar 17
Regulation FD Disclosure
12:00am
8-K
lvs q6h70rytua4
6 Mar 17
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
2lbkqp
28 Nov 16
PhaseRx Receives Orphan Drug Designation from FDA for PRX-OTC for the Treatment of Ornithine Transcarbamylase Deficiency
12:00am
8-K
f4m1zw9
8 Nov 16
Regulation FD Disclosure
12:00am
8-K
7nblctqw b8p
7 Nov 16
PhaseRx Reports Third Quarter 2016 Financial Results and Provides Corporate Update
12:00am
8-K
nmwb9gswdv26m x5npb
24 Aug 16
Departure of Directors or Certain Officers
12:00am
S-8
rry 5jdabk2ib03w
12 Aug 16
Registration of securities for employees
12:00am
10-Q
gkb5qebthh5obhh7h9m9
2 Aug 16
Quarterly report
12:00am